Literature DB >> 10072440

Isolation and embryonic expression of the novel mouse gene Hic1, the homologue of HIC1, a candidate gene for the Miller-Dieker syndrome.

C Grimm1, R Spörle, T E Schmid, I D Adler, J Adamski, K Schughart, J Graw.   

Abstract

The human gene HIC1 (hypermethylated in cancer) maps to chromosome 17p13.3 and is deleted in the contiguous gene disorder Miller-Dieker syndrome (MDS) [Makos-Wales et al. (1995) Nature Med., 1, 570-577; Chong et al. (1996) Genome Res., 6, 735-741]. We isolated the murine homologue Hic1, encoding a zinc-finger protein with a poxvirus and zinc-finger (POZ) domain and mapped it to mouse chromosome 11 in a region exhibiting conserved synteny to human chromosome 17. Comparison of genomic and cDNA sequences predicts two exons for the murine Hic1. The second exon exhibits 88% identity to the human HIC1 on DNA level. During embryonic development, Hic1 is expressed in mesenchymes of the sclerotomes, lateral body wall, limb and cranio-facial regions embedding the outgrowing peripheral nerves during their differentiation. During fetal development, Hic1 additionally is expressed in mesenchymes apposed to precartilaginous condensations, at many interfaces to budding epithelia of inner organs, and weakly in muscles. We observed activation of Hic1 expression in the embryonic anlagen of many tissues displaying anomalies in MDS patients. Besides lissencephaly, MDS patients exhibit facial dysmorphism and frequently additional birth defects, e.g. anomalies of the heart, kidney, gastrointestinal tract and the limbs (OMIM 247200). Thus, HIC1 activity may correlate with the defective development of the nose, jaws, extremities, gastrointestinal tract and kidney in MDS patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072440     DOI: 10.1093/hmg/8.4.697

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  17 in total

Review 1.  Miller-Dieker syndrome: analysis of a human contiguous gene syndrome in the mouse.

Authors:  Jessica Yingling; Kazuhito Toyo-Oka; Anthony Wynshaw-Boris
Journal:  Am J Hum Genet       Date:  2003-08-05       Impact factor: 11.025

Review 2.  DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer.

Authors:  Yutaka Hashimoto; Timothy J Zumwalt; Ajay Goel
Journal:  Epigenomics       Date:  2016-04-22       Impact factor: 4.778

3.  Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B.

Authors:  S Deltour; C Guerardel; D Leprince
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

4.  The transcription factor Hypermethylated in Cancer 1 (Hic1) regulates neural crest migration via interaction with Wnt signaling.

Authors:  Heather Ray; Chenbei Chang
Journal:  Dev Biol       Date:  2020-06-02       Impact factor: 3.582

5.  Antagonistic action of Six3 and Prox1 at the gamma-crystallin promoter.

Authors:  J Lengler; E Krausz; S Tomarev; A Prescott; R A Quinlan; J Graw
Journal:  Nucleic Acids Res       Date:  2001-01-15       Impact factor: 16.971

6.  Hic1 Defines Quiescent Mesenchymal Progenitor Subpopulations with Distinct Functions and Fates in Skeletal Muscle Regeneration.

Authors:  R Wilder Scott; Martin Arostegui; Ronen Schweitzer; Fabio M V Rossi; T Michael Underhill
Journal:  Cell Stem Cell       Date:  2019-12-05       Impact factor: 24.633

7.  Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia.

Authors:  Astanand Jugessur; Min Shi; Håkon Kristian Gjessing; Rolv Terje Lie; Allen James Wilcox; Clarice Ring Weinberg; Kaare Christensen; Abee Lowman Boyles; Sandra Daack-Hirsch; Truc Trung Nguyen; Lene Christiansen; Andrew Carl Lidral; Jeffrey Clark Murray
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

8.  The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif.

Authors:  Sophie Deltour; Sébastien Pinte; Cateline Guerardel; Bohdan Wasylyk; Dominique Leprince
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

9.  Superoxide dismutase 3, extracellular (SOD3) variants and lung function.

Authors:  Koustav Ganguly; Martin Depner; Cheryl Fattman; Kiflai Bein; Tim D Oury; Scott C Wesselkamper; Michael T Borchers; Martina Schreiber; Fei Gao; Erika von Mutius; Michael Kabesch; George D Leikauf; Holger Schulz
Journal:  Physiol Genomics       Date:  2009-03-24       Impact factor: 3.107

10.  The duplication 17p13.3 phenotype: analysis of 21 families delineates developmental, behavioral and brain abnormalities, and rare variant phenotypes.

Authors:  Cynthia J Curry; Jill A Rosenfeld; Erica Grant; Karen W Gripp; Carol Anderson; Arthur S Aylsworth; Taha Ben Saad; Victor V Chizhikov; Giedre Dybose; Christina Fagerberg; Michelle Falco; Christina Fels; Marco Fichera; Jesper Graakjaer; Donatella Greco; Jennifer Hair; Elizabeth Hopkins; Marlene Huggins; Roger Ladda; Chumei Li; John Moeschler; Malgorzata J M Nowaczyk; Jillian R Ozmore; Santina Reitano; Corrado Romano; Laura Roos; Rhonda E Schnur; Susan Sell; Pim Suwannarat; Dea Svaneby; Marta Szybowska; Mark Tarnopolsky; Raymond Tervo; Anne Chun-Hui Tsai; Megan Tucker; Stephanie Vallee; Ferrin C Wheeler; Dina J Zand; A James Barkovich; Swaroop Aradhya; Lisa G Shaffer; William B Dobyns
Journal:  Am J Med Genet A       Date:  2013-06-27       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.